MDGL INVESTIGATION NOTICE: Hagens Berman, National Securities Law Firm, Investigating Madrigal Pharmaceuticals (NASDAQ: MDGL) Following Whistleblower Allegations of Clinical Data Integrity Concerns

SAN FRANCISCO, Nov. 11, 2026 /PRNewswire/ -- Hagens Berman, a national complex securities litigation law firm, announces an investigation into Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL). The inquiry focuses on whether Madrigal and senior management misrepresented or concealed material...

Published on The Global News Feed

11 Nov 2026, 13:50 UTC